News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
853,019 Results
Type
Article (86892)
Company Profile (704)
Press Release (765422)
Multimedia
Podcasts (147)
Webinars (19)
Section
Business (232823)
Career Advice (4133)
Deals (39763)
Drug Delivery (129)
Drug Development (91112)
Employer Resources (198)
FDA (18192)
Job Trends (17366)
News (396861)
Policy (39826)
Tag
Academia (3002)
Academic (2)
Accelerated approval (12)
Adcomms (32)
Allergies (106)
Alliances (56975)
ALS (120)
Alzheimer's disease (1572)
Antibody-drug conjugate (ADC) (188)
Approvals (18141)
Artificial intelligence (401)
Autoimmune disease (37)
Automation (19)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (137)
Biotechnology (482)
Bladder cancer (100)
Brain cancer (41)
Breast cancer (392)
Cancer (3103)
Cardiovascular disease (249)
Career advice (3542)
Career pathing (34)
CAR-T (209)
CDC (41)
Cell therapy (576)
Cervical cancer (24)
Clinical research (74331)
Collaboration (1114)
Company closure (3)
Compensation (715)
Complete response letters (34)
COVID-19 (2905)
CRISPR (68)
C-suite (359)
Cystic fibrosis (122)
Data (3104)
Decentralized trials (2)
Denatured (51)
Depression (78)
Diabetes (380)
Diagnostics (6982)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (183)
Drug pricing (152)
Drug shortages (36)
Duchenne muscular dystrophy (138)
Earnings (97536)
Editorial (48)
Employer branding (25)
Employer resources (169)
Events (131481)
Executive appointments (910)
FDA (19942)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1020)
Gene editing (149)
Generative AI (40)
Gene therapy (439)
GLP-1 (937)
Government (5265)
Grass and pollen (6)
Guidances (182)
Healthcare (20917)
HIV (45)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (185)
Immuno-oncology (11)
Indications (40)
Infectious disease (3102)
Inflammatory bowel disease (165)
Inflation Reduction Act (13)
Influenza (71)
Intellectual property (125)
Interviews (813)
IPO (17906)
IRA (55)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (57)
Layoffs (594)
Leadership (27)
Legal (10137)
Liver cancer (85)
Longevity (12)
Lung cancer (435)
Lymphoma (216)
Machine learning (11)
Management (65)
Manufacturing (448)
MASH (100)
Medical device (14733)
Medtech (14738)
Mergers & acquisitions (22586)
Metabolic disorders (969)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (145)
Neuropsychiatric disorders (43)
Neuroscience (2333)
NextGen: Class of 2025 (7687)
Non-profit (5090)
Now hiring (49)
Obesity (496)
Opinion (291)
Ovarian cancer (104)
Pain (122)
Pancreatic cancer (126)
Parkinson's disease (201)
Partnered (25)
Patents (323)
Patient recruitment (174)
Peanut (55)
People (65731)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22941)
Phase II (32274)
Phase III (24301)
Pipeline (1709)
Policy (243)
Postmarket research (3552)
Preclinical (10360)
Press Release (72)
Prostate cancer (150)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (529)
Real estate (7402)
Recruiting (76)
Regulatory (27189)
Reports (61)
Research institute (2666)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (10)
RSV (58)
Schizophrenia (99)
Series A (173)
Series B (118)
Service/supplier (30)
Sickle cell disease (67)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (4305)
State (2)
Stomach cancer (17)
Supply chain (84)
Tariffs (65)
The Weekly (94)
Vaccines (919)
Venture capital (58)
Weight loss (332)
Women's health (52)
Worklife (20)
Date
Today (83)
Last 7 days (390)
Last 30 days (2045)
Last 365 days (34009)
2025 (18558)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1273)
Alabama (70)
Alaska (7)
Arizona (281)
Arkansas (14)
Asia (50545)
Australia (8879)
California (7813)
Canada (2421)
China (728)
Colorado (340)
Connecticut (349)
Delaware (205)
Europe (115957)
Florida (1160)
Georgia (264)
Hawaii (2)
Idaho (66)
Illinois (744)
India (33)
Indiana (386)
Iowa (19)
Japan (239)
Kansas (116)
Kentucky (33)
Louisiana (18)
Maine (73)
Maryland (1109)
Massachusetts (5976)
Michigan (276)
Minnesota (487)
Mississippi (3)
Missouri (101)
Montana (32)
Nebraska (26)
Nevada (83)
New Hampshire (73)
New Jersey (2193)
New Mexico (31)
New York (2191)
North Carolina (1250)
North Dakota (10)
Northern California (3366)
Ohio (253)
Oklahoma (17)
Oregon (48)
Pennsylvania (1666)
Puerto Rico (18)
Rhode Island (39)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2896)
Tennessee (129)
Texas (1198)
United States (29505)
Utah (231)
Virginia (215)
Washington D.C. (80)
Washington State (692)
West Virginia (4)
Wisconsin (86)
There are 853,019 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Government
CDER Employees Leave FDA in Droves Amid HHS Overhaul
In the first 6 months of 2025, 385 employees resigned from the Center for Drug Evaluation and Research, compared with under 130 staff during the same period last year.
July 17, 2025
·
2 min read
·
Tristan Manalac
Neuropsychiatric disorders
Otsuka, Lundbeck’s PTSD Bid for Rexulti Hits Speedbump as FDA Questions Efficacy
FDA reviewers flag “discordant results” in a briefing document published ahead of Friday’s advisory committee meeting for the partners’ application for the antipsychotic in post-traumatic stress disorder.
July 17, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Bristol Myers Squibb and Pfizer Announce Direct-to-Patient Eliquis® (apixaban) Option
July 17, 2025
·
13 min read
Press Releases
Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025
July 17, 2025
·
3 min read
Press Releases
Immuron - FY25 global sales exceed projection, up 49% on prior year
July 17, 2025
·
4 min read
Job Trends
6 Companies Hiring in Illinois
Looking for a biopharma job in Illinois? Check out the
BioSpace
list of six companies hiring life sciences professionals like you.
July 17, 2025
·
1 min read
·
Angela Gabriel
Job Trends
Adapting in Uncertain Times: Biopharma Professionals Turn To Fractional Roles
1 in 5 respondents either have had or do have a fractional role, according to a recent
BioSpace
poll, and over half are considering it. Two recruitment experts, a fractional worker and an aspiring fractional worker share their insights.
July 17, 2025
·
6 min read
·
Angela Gabriel
Press Releases
Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance
July 17, 2025
·
21 min read
Press Releases
VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC
July 17, 2025
·
12 min read
Press Releases
Pharming Group to report second quarter and first half 2025 financial results and provide business update on July 31
July 17, 2025
·
1 min read
1 of 85,302
Next
